Digestive Diseases and Sciences

, Volume 61, Issue 9, pp 2516–2521 | Cite as

Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro

  • Tao Liu
  • Wenting He
  • Yumin Li
Original Article



Helicobacter pylori infection is exceptionally prevalent, and it is an important risk factor for gastritis, gastroduodenal ulcers, and gastric cancer. However, the pathogenic mechanisms of H. pylori are not entirely clear. The aim of this study was to assess which signal pathway is initially activated by H. pylori.


Using the Human Signal Transduction Pathway Finder RT2 Profiler PCR Array, we screened for alterations in the expression of genes encoding members of ten different signal transduction pathways in GES-1 cells co-cultured with H. pylori. qPCR and Western blotting were used to verify the expression of four key genes in NOTCH pathway.


Of the 84 genes represented in the array, 22 genes demonstrated more than twofold difference (p < 0.05) in GES-1 cells grown in the presence of H. pylori 11637 compared to cells without H. pylori 11637. Ten genes were up-regulated in the co-culture group, whereas 12 appeared to be down-regulated. Further analysis using the SA Biosciences online program revealed that NOTCH pathway was the most significantly affected network. There was a significant reduction in the mRNA expression level of NOTCH1 and NOTCH2, together with a reduced level of active forms of NOTCH1 (NICD1) and NOTCH2 (NICD2). Meanwhile, the expression level of the ligand DLL4 was found to be significantly increased.


NOTCH signaling may play an important role in H. pylori-induced gastric carcinogenesis.


Helicobacter pylori Gastric epithelial cells NOTCH 



This study was supported by National Natural Science Foundation of China (Grant Nos. 31270532, 31300429, and 31560157), Natural Science Foundation of Gansu Province (Grant No. 1506RJYA203), and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2014-164).

Compliance with ethical standards

Conflict of interest

The authors declare no competing interests.


  1. 1.
    Herrera V, Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect. 2009;15:971–976.CrossRefPubMedGoogle Scholar
  2. 2.
    de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;2012:607–615.CrossRefGoogle Scholar
  3. 3.
    International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, 1994:218–220.Google Scholar
  4. 4.
    Galmiche A, Rassow J. Targeting of Helicobacter pylori VacA to mitochondria. Gut Microbes. 2010;1:392–395.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Foo JH, Culvenor JG, Ferrero RL, et al. Both the p33 and p55 subunits of the Helicobacter pylori VacA toxin are targeted to mammalian mitochondria. J Mol Biol. 2010;401:792–798.CrossRefPubMedGoogle Scholar
  6. 6.
    Tegtmeyer N, Wessler S, Backert S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 2011;278:1190–1202.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Saadat I, Higashi H, Obuse C, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330–333.CrossRefPubMedGoogle Scholar
  8. 8.
    Ferrand J, Lehours P, Schmid-Alliana A, et al. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PLoS One. 2011;6:e29007.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nagy TA, Frey MR, Yan F, et al. Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling. J Infect Dis. 2009;199:641–651.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tsang YH, Lamb A, Romero-Gallo J, et al. Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene. 2010;29:5643–5650.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wang H, SunY Liu S, et al. Upregulation of progranulin by Helicobacter pylori in human gastric epithelial cells via p38MAPK and MEK1/2 signaling pathway: role in epithelial cell proliferation and migration. FEMS Immunol Med Microbiol. 2011;63:82–92.CrossRefPubMedGoogle Scholar
  12. 12.
    Liu Z, Xu X, Chen L, et al. Helicobacter pylori CagA inhibits the expression of Runx3 via Src/MEK/ERK and p38 MAPK pathways in gastric epithelial cell. J Cell Biochem. 2012;113:1080–1086.CrossRefPubMedGoogle Scholar
  13. 13.
    Radtke F, Fasnacht N, MacDonald HR. Notch signaling in the immune system. Immunity. 2010;32:14–27.CrossRefPubMedGoogle Scholar
  14. 14.
    Shi Y, Liu XF, Zhuang Y, et al. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol. 2010;184:5121–5129.CrossRefPubMedGoogle Scholar
  15. 15.
    Amsen D, Antov A, Jankovic D, et al. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity. 2007;27:89–99.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Sun J, Krawczyk CJ, Pearce EJ. Suppression of Th2 cell development by Notch ligands Delta1 and Delta4. J Immunol. 2008;180:1655–1661.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Skokos D, Nussenzweig MC. CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J Exp Med. 2007;204:1525–1531.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Palaga T, Miele L, Golde TE, et al. TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J Immunol. 2003;171:3019–3024.CrossRefPubMedGoogle Scholar
  19. 19.
    Adler SH, Chiffoleau E, Xu L, et al. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J Immunol. 2003;171:2896–2903.CrossRefPubMedGoogle Scholar
  20. 20.
    Cho OH, Shin HM, Miele L, et al. Notch regulates cytolytic effector function in CD8+ T cells. J Immunol. 2009;182:3380–3389.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Maekawa Y, Minato Y, Ishifune C, et al. Notch2 integrates signaling by the transcription factors RBP-J and CREB1 to promote T cell cytotoxicity. Nat Immunol. 2008;9:1140–1147.CrossRefPubMedGoogle Scholar
  22. 22.
    Ayaz F, Osborne BA. Non-canonical notch signaling in cancer and immunity. Front Oncol. 2014;4:Article 345.Google Scholar
  23. 23.
    LaVoie MJ, Selkoe DJ. The Notch ligands, Jagged and Delta, are sequentially processed by α-secretase and presenilin/γ-secretase and release signaling fragments. J Biol Chem. 2003;278:34427–34437.CrossRefPubMedGoogle Scholar
  24. 24.
    Six E, Ndiaye D, Laabi Y, et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and γ-secretase. Proc Natl Acad Sci USA.. 2003;100:7638–7643.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Kolev V, Kacer D, Trifonova R, et al. The intracellular domain of Notch ligand Delta1 induces cell growth arrest. FEBS Lett. 2005;25:5798–5802.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Second Hospital of Lanzhou UniversityLanzhouChina
  2. 2.Key Laboratory of Digestive System TumorsLanzhouChina

Personalised recommendations